Red grape polyphenol, resveratrol: a multifaceted therapeutic powerhouse under review
Can't see this email? View it online
   
  Prostate Cancer  
  The latest prostate cancer news from News Medical  
 Multi-ancestry study reveals 187 new genetic risk factors for prostate cancerMulti-ancestry study reveals 187 new genetic risk factors for prostate cancer
 
In a comprehensive multi-ancestry GWAS meta-analysis, researchers identified 451 risk variants for prostate cancer, including 187 new variants, demonstrating the utility of such studies across diverse populations.
 
 
 Red grape polyphenol, resveratrol: a multifaceted therapeutic powerhouse under reviewRed grape polyphenol, resveratrol: a multifaceted therapeutic powerhouse under review
 
The therapeutic potential of resveratrol, a red grape polyphenol.
 
   UTHSC's drug candidate for advanced prostate cancer goes to first clinical trialUTHSC's drug candidate for advanced prostate cancer goes to first clinical trial
 
A drug candidate developed by researchers at the University of Tennessee Health Science Center for advanced metastatic castration-resistant prostate cancer is now in its first clinical trial.
 
   Highly sensitive blood test  shows promise for early detection of common deadly cancersHighly sensitive blood test shows promise for early detection of common deadly cancers
 
Most cancers become deadly by keeping a low profile, causing no symptoms until they're too advanced to treat. Ovarian and gastroesophageal cancers are among the most notorious for this sly disease progression, often leading to late-stage diagnoses.
 
   Exploring the impact of soy isoflavones in prostate cancer therapyExploring the impact of soy isoflavones in prostate cancer therapy
 
The cellular mechanisms of soy isoflavones, genistein, daidzein, and equol.
 
 AdvanCell reaches milestone as first prostate cancer patient dosed with 212Pb-ADVC001
 
AdvanCell reaches milestone as first prostate cancer patient dosed with 212Pb-ADVC001AdvanCell, a radiopharmaceutical company developing a pipeline of Targeted Alpha Therapies for cancer patients, today announced the first patient was treated with 212Pb-ADVC001, a Targeted Alpha Therapy in development for the treatment of PSMA-positive metastatic Castration-Resistant Prostate Cancer (mCRPC).
 
 
 Study compiles the most comprehensive list of genetic variants associated with prostate cancer risk
 
Study compiles the most comprehensive list of genetic variants associated with prostate cancer riskA globe-spanning scientific team has compiled the most comprehensive list of genetic variants associated with prostate cancer risk -; 451 in all -; through a whole-genome analysis that ranks as the largest and most diverse investigation into prostate cancer genetics yet.
 
 
 Study shows linear associations between body mass index and site-specific tumors in young males
 
Study shows linear associations between body mass index and site-specific tumors in young malesThe associations between body mass index (BMI) among young males and new-onset site-specific tumors.
 
 
 Study offers the most comprehensive look to date on prostate cancer disparities
 
Study offers the most comprehensive look to date on prostate cancer disparitiesCedars-Sinai Cancer investigators have found that Black men respond as well as white men to systemic therapies for advanced prostate cancer when access to quality healthcare is equal, regardless of socioeconomic status.
 
 
 High BMI in late teens linked to higher risk of 17 different cancers later in life
 
High BMI in late teens linked to higher risk of 17 different cancers later in lifeMen who are overweight or obese at age 18 have a higher risk of 17 different cancers later in life. This has been shown in a study at the University of Gothenburg.
 
 
 Research opens the door to a potential treatment strategy for certain advanced prostate cancers
 
Research opens the door to a potential treatment strategy for certain advanced prostate cancersEpigenetic changes can cause prostate cancer to resist treatment by switching genes on or off. One epigenetic mechanism tags genes with DNA methylation marks.
 
 
 Study finds 4% of Icelanders to carry an actionable genotype associated with shortened lifespan
 
Study finds 4% of Icelanders to carry an actionable genotype associated with shortened lifespanScientists at deCODE genetics, a subsidiary of Amgen, have published a study on actionable genotypes detected in the Icelandic population and their association with lifespan.
 
 
 Docetaxel improves survival in men with high-grade prostate cancer and low PSA
 
Docetaxel improves survival in men with high-grade prostate cancer and low PSAMen with high-grade prostate cancer and low prostate-specific antigen (PSA) levels have a poor prognosis.
 
 
 Black men may face an increased risk of prostate cancer than white men at lower PSA levels
 
Black men may face an increased risk of prostate cancer than white men at lower PSA levelsBlack men in the United States are more likely to develop prostate cancer than white men, and after diagnosis, they're more likely to have advanced disease and to die than white men with the disease.
 
 
 Gender concordance between patient and surgeon may not affect mortality rates, study finds
 
Gender concordance between patient and surgeon may not affect mortality rates, study findsNew research finds little evidence that post-surgical patient mortality is lower when patient and surgeon are the same gender.